Fundraising Fox

Invenra

Madison, US · Founded 2011 · Delaware corporation · 2 known investors

invenra.com ↗

Invenra develops proprietary platform technologies to discover and develop novel bi- and multi-specific antibody therapies, with an initial focus on oncology. The company is advancing pipelines of antibody candidates with partners and intends to expand into additional disease categories.

BiotechHealthtech

Founders & leadership

Invenra was founded in 2011 by Roland Green.

RGRoland Green
Roland GreenFounder

Board

EN
Emile NuwaysirBoard director
SR
Stan RoseBoard director
RL
Richard LesniewskiBoard director
DS
David SnyderBoard director

Investors · 2

Venture ManagementMadison
Wisconsin Investment PartnersMadison · $5K – $100K

Reported raises · per SEC filings

Form D private placements

$18.3M disclosed across 6 rounds · 2012–2018

▶$7.1MraisedOct 2018 · 23 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Roland GreenExecutive Officer, Director
  • Paul WeissDirector
  • Emile NuwaysirDirector
  • Richard LesniewskiDirector
  • Stan RoseDirector
  • David SnyderDirector
Offering amount
$7.1M
Amount sold
$7.1M
First sale
Oct 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.9MraisedOct 2017 · 25 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • David SnyderDirector
  • Richard LesniewskiDirector
  • Emile NuwaysirDirector
  • Roland GreenExecutive Officer, Director
  • Stan RoseDirector
Offering amount
$6M
Amount sold
$2.9M
First sale
Sep 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedJul 2016 · 27 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Stan RoseDirector
  • Richard LesniewskiDirector
  • David SnyderDirector
  • Emile NuwaysirDirector
  • Roland GreenExecutive Officer, Director
Offering amount
$3M
Amount sold
$3M
First sale
Jul 2016
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedAug 2015 · 28 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Emile NuwaysirDirector
  • Stan RoseDirector
  • Roland GreenExecutive Officer, Director
  • David SnyderDirector
  • Richard LesniewskiDirector
Offering amount
$2M
Amount sold
$2M
First sale
Aug 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedJan 2015 · 25 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Emile NuwaysirDirector
  • Stan RoseDirector
  • Richard LesniewskiDirector
  • David SnyderDirector
  • Roland GreenExecutive Officer, Director
Offering amount
$2M
Amount sold
$2M
First sale
Jan 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedJan 2012 · 18 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Roland GreenExecutive Officer, Director
  • Emile NuwaysirDirector
Offering amount
$1.2M
Amount sold
$1.2M
First sale
Jan 2012
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06, 46
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
IQVIA29 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.

Companies competing with Invenra for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Invenra do?
Invenra develops proprietary platform technologies to discover and develop novel bi- and multi-specific antibody therapies, with an initial focus on oncology. The company is advancing pipelines of antibody candidates with partners and intends to expand into additional disease categories.
Who founded Invenra?
Invenra was founded by Roland Green in 2011.
Who are Invenra's investors?
Invenra's investors include Venture Management, Wisconsin Investment Partners.
How much funding has Invenra raised?
Invenra has disclosed $18.3M raised across 6 rounds.
Where is Invenra headquartered?
Invenra is headquartered in Madison, US.